We are live on ! Find out more
GCM

Glenview Capital Management Portfolio holdings

AUM $3.98B
1-Year Est. Return 20.52%
This Fund
S&P 500
This Quarter Est. Return
-17.12%
1 Year Est. Return
+20.52%
3 Year Est. Return
+68.18%
5 Year Est. Return
+87.14%
10 Year Est. Return
+400.35%
AUM
$10.3B
AUM Growth
-$5.42B
Cap. Flow
-$3B
Cap. Flow %
-29.02%
Top 10 Hldgs %
54.96%
Holding
62
New
4
Increased
17
Reduced
26
Closed
12

Top Buys

Rank Stock Value
1
CI icon
Cigna
CI
+$363M
2
DXC icon
DXC Technology
DXC
+$306M
3
SHPG
Shire pic
SHPG
+$285M
4
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$144M
5
CVS icon
CVS Health
CVS
+$140M

Top Sells

Rank Stock Value
1
ESRX
Express Scripts Holding Company
ESRX
+$817M
2
AET
Aetna Inc
AET
+$732M
3
NWL icon
Newell Brands
NWL
+$394M
4
TMO icon
Thermo Fisher Scientific
TMO
+$242M
5
AGN
Allergan plc
AGN
+$240M

Sector Composition

Rank Sector Weight
1 Healthcare 53.29%
2 Materials 13%
3 Technology 8.91%
4 Industrials 8.58%
5 Communication Services 8.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BKD icon
26
Brookdale Senior Living
BKD
$3B
$97.4M 0.94%
14,535,690
+4,072,764
+39% +$34.2M
CAR icon
27
Avis
CAR
$4.97B
$96.9M 0.94%
4,311,035
-25,737
-0.6% -$747K
LBTYK icon
28
Liberty Global Class C
LBTYK
$3.4B
$94.1M 0.91%
4,557,652
-522,769
-10% -$12.5M
ESI icon
29
Element Solutions
ESI
$9.17B
$93.8M 0.91%
9,079,815
-3,414,407
-27% -$37.6M
ARMK icon
30
Aramark
ARMK
$15.9B
$87.6M 0.85%
4,185,967
-7,381,111
-64% -$192M
LYB icon
31
LyondellBasell Industries
LYB
$20.7B
$81.4M 0.79%
978,845
+518,545
+113% +$47.4M
NXPI icon
32
NXP Semiconductors
NXPI
$59.6B
$80.4M 0.78%
1,097,045
-938,810
-46% -$74.3M
APTV icon
33
Aptiv
APTV
$10.3B
$80.4M 0.78%
1,305,249
-154,012
-11% -$11.2M
NUAN
34
DELISTED
Nuance Communications, Inc.
NUAN
$79.9M 0.77%
6,976,913
-4,464,981
-39% -$62.6M
LOW icon
35
Lowe's Companies
LOW
$124B
$74.3M 0.72%
804,215
-392,613
-33% -$37.9M
WBA
36
DELISTED
Walgreens Boots Alliance
WBA
$65.7M 0.64%
961,747
-2,913,484
-75% -$226M
FDX icon
37
FedEx
FDX
$76.3B
$58.2M 0.56%
360,551
-1,049,870
-74% -$222M
BAX icon
38
Baxter International
BAX
$14.3B
$57.7M 0.56%
+877,001
New +$58.9M
HTZ
39
DELISTED
Hertz Global Holdings, Inc.
HTZ
$57.4M 0.56%
4,841,879
-700,371
-13% -$9.84M
HUM icon
40
Humana
HUM
$44.8B
$53.1M 0.51%
+185,195
New +$58.7M
CI icon
41
CALL
Cigna
CI
$72.4B
$47.5M 0.46%
250,000
– –
DLPH
42
DELISTED
Delphi Technologies PLC Ordinary Shares
DLPH
$39.8M 0.39%
2,781,149
+467,801
+20% +$9.11M
VER
43
DELISTED
VEREIT, Inc.
VER
$33.1M 0.32%
925,014
-844,708
-48% -$31.4M
ENDP
44
DELISTED
Endo International plc
ENDP
$32.7M 0.32%
4,478,336
-8,545,202
-66% -$117M
AGN
45
DELISTED
Allergan plc
AGN
$26.9M 0.26%
200,971
-1,462,833
-88% -$240M
ALB icon
46
Albemarle
ALB
$15.3B
$26.5M 0.26%
343,932
– –
CNDT icon
47
Conduent
CNDT
$245M
$23.1M 0.22%
2,173,949
+172,722
+9% +$2.69M
LTHM
48
DELISTED
Livent Corporation
LTHM
$21M 0.2%
+1,519,910
New +$24.8M
DD icon
49
CALL
DuPont de Nemours
DD
$19.5B
$16M 0.16%
+118,464
New +$17M
COR icon
50
Cencora
COR
$63.7B
$13.1M 0.13%
176,348
-747,332
-81% -$64.4M
1
2
3

Similar funds

MAM
Martingale Asset Management Boston, Massachusetts $3.99B AUM 22.65% 1-Year Est. Return
USCWA
U.S. Capital Wealth Advisors Austin, Texas $3.98B AUM 22.36% 1-Year Est. Return
JSW
Journey Strategic Wealth Summit, New Jersey $4.03B AUM 33.12% 1-Year Est. Return
AS
American Securities New York $3.93B AUM 52.22% 1-Year Est. Return
BWA
Brave Warrior Advisors New York $4.04B AUM 1.15% 1-Year Est. Return
BCP
BSN Capital Partners London, United Kingdom $3.93B AUM 13.09% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
ICP
Ilex Capital Partners London, United Kingdom $4.06B AUM 6.11% 1-Year Est. Return

Glenview Capital Management's Q4 2018 Portfolio in Review

As of Q4 2018, Glenview Capital Management held 62 positions worth $10.3B, down 34% from $15.7B the previous quarter. Its ten largest holdings account for 55% of the portfolio.

Glenview Capital Management withdrew a net $3B in Q4 2018, closing 12 positions and reducing 26 holdings. Its most notable exit was Express Scripts Holding Company, an estimated $817M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 53% of assets, up from 46% a quarter earlier, followed by Materials and Technology.

Against the trend, Glenview Capital Management opened a new position in Baxter International worth $57.7M.

  • Glenview Capital Management's largest Q4 2018 buy was Baxter International: 877,001 shares worth $57.7M.
  • Glenview Capital Management added most to Cigna in Q4 2018, an estimated $363M increase.
  • Glenview Capital Management's biggest Q4 2018 reduction was Thermo Fisher Scientific, cutting an estimated $242M.
  • Glenview Capital Management fully exited Express Scripts Holding Company in Q4 2018, selling an estimated $817M.
  • Glenview Capital Management's ten largest holdings make up 55% of its $10.3B portfolio in Q4 2018.
  • Glenview Capital Management opened 4 new positions and closed 12 in Q4 2018.
  • Glenview Capital Management's portfolio value fell 34% quarter-over-quarter to $10.3B.

Based on Glenview Capital Management's 13F filing for Q4 2018, filed 14 Feb 2019.